LEVTEL-M 2.5 is a combination tablet containing Montelukast Sodium and Levocetirizine Hydrochloride, formulated for the management of certain allergic and respiratory symptoms.
Montelukast is a leukotriene receptor antagonist that helps reduce the effects of leukotrienes involved in allergic and airway inflammation. Levocetirizine is an antihistamine that helps relieve allergy-related symptoms such as sneezing, runny nose, nasal congestion and itching.
The combination may be prescribed for patients experiencing allergic rhinitis and related respiratory or allergy symptoms. LEVTEL-M 2.5 should be used according to the dosage and duration recommended by a healthcare professional.
Composition
- Montelukast Sodium equivalent to Montelukast — 4 mg
- Levocetirizine Hydrochloride IP — 2.5 mg
- Excipients — q.s.
Indications / Uses
LEVTEL-M 2.5 may be prescribed for:
- Allergic rhinitis
- Seasonal allergy symptoms
- Sneezing and runny nose
- Nasal itching associated with allergies
- Allergy-related respiratory symptoms
- Other allergic conditions as advised by a healthcare professional
Key Benefits
- Combination of Montelukast and Levocetirizine
- Helps relieve common allergy symptoms
- Supports management of allergic rhinitis
- Helps reduce sneezing, runny nose and nasal itching
- Montelukast helps manage leukotriene-mediated airway inflammation
- Convenient tablet dosage form
